Bio-Techne
TECH
#1437
Rank
A$18.63 B
Marketcap
$117.44
Share price
-2.56%
Change (1 day)
6.37%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of June 2024 : A$0.62 B

According to Bio-Techne's latest financial reports the company's total debt is A$0.62 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30A$0.68 B44.82%
2022-06-30A$0.47 B-15.93%
2021-06-30A$0.56 B-10.86%
2020-06-30A$0.62 B-12.55%
2019-06-30A$0.71 B57.1%
2018-06-30A$0.45 B2.27%
2017-06-30A$0.44 B249%
2016-06-30A$0.12 B28.45%
2015-06-30A$99.88 M627.06%
2014-06-30A$13.73 M
2006-06-30A$18.15 M-5.23%
2005-06-30A$19.15 M-16.57%
2004-06-30A$22.95 M-10.26%
2003-06-30A$25.58 M-20.44%
2002-06-30A$32.15 M-13.09%
2001-06-30A$37 M12.54%
2000-06-30A$32.87 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
A$53.10 B 8,339.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.08 B 231.95%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.98 B 4,505.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$25.51 B 3,954.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.10 B 234.09%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$29.50 B 4,589.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.88 M-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA